Listar por autor "Del Campo-Herrera, Enrique"
Mostrando ítems 1-5 de 5
-
Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage
Cueto-Sánchez, Alejandro; Niu, Hao; Alvarez-Alvarez, Ismael; López-Longarela, Bárbara; Del Campo-Herrera, Enrique; Ortega-Alonso, Aida; García-Cortés, Miren
; Pinazo-Bandera, José M.; Sanabria-Cabrera, Judith Adriana; Díaz-Monchón, Juan José; Lucena-González, María Isabel; Andrade-Bellido, Raúl Jesús; Stephens, Camilla; Robles-Díaz, María Mercedes[et al.] (Wiley, 2023)
Aims Detection and characterization of idiosyncratic drug-induced liver injury (DILI) currently rely on standard liver tests, which are suboptimal in terms of specificity, sensitivity and prognosis. Therefore, DILI diagnosis ... -
Hepatitis C virus point-of-care microelimination approach in a vulnerable population in the South of Spain.
Pinazo-Bandera, Jose M.; Aranda, Jesús; García-García, Alberto M.; Alcántara, Ramiro; Ortega-Alonso, Aida; Del Campo-Herrera, Enrique; Clavijo-Frutos, Encarnación; García-Escaño, M. Dolores; Ruiz Ruiz, Juan J.; Morales-Herrera, Mónica; Valle-López, Vanesa; Martín-Alarcón, Rosa; Viciana, Isabel; Jiménez, Juan Bautista; Fernández-García, Félix; Toro-Ortiz, Juan Pedro; Sánchez-Yáñez, Elena; Alvarez-Alvarez, Ismael; Andrade-Bellido, Raúl Jesús; Robles-Díaz, María Mercedes; García-Cortés, Miren[et al.] (Oxford Academic, 2024-01-22)
Background: Since the introduction of direct-acting antivirals, thousands of chronic hepatitis C patients have been successfully treated. However, vulnerable populations have a higher prevalence of hepatitis C virus (HCV) ... -
Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study
Cueto-Sánchez, Alejandro; Niu, Hao; Del Campo-Herrera, Enrique; Robles-Díaz, María Mercedes; Sanabria-Cabrera, Judith Adriana; Ortega-Alonso, Aida; García-Cortés, Miren; González-Grande, Rocío; Jiménez-Pérez, Miguel; Ruiz-Cabello, Francisco; Andrade-Bellido, Raúl Jesús; Lucena-González, María Isabel[et al.] (Wiley, 2021-09-20)
The identification of specific HLA risk alleles in drug-induced liver injury (DILI) points toward an important role of the adaptive immune system in DILI development. In this study, we aimed to corroborate the role of an ... -
Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions
Pinazo-Bandera, José M.; Niu, Hao; Alvarez-Alvarez, Ismael; Medina-Cáliz, Inmaculada; Del Campo-Herrera, Enrique; Ortega-Alonso, Aida; Robles-Díaz, María Mercedes; Hernandez, Nelia; Parana, Raymundo; Nunes, Vinicius; Girala, M.; Bessone, Fernando; Lucena-González, María Isabel; Andrade-Bellido, Raúl Jesús; García-Cortés, Miren[et al.] (Elsevier, 2024-05)
Los datos sobre la reexposición positiva en la lesión hepática inducida por fármacos (DILI) idiosincrásica son escasos. Apuntamos a analizar la presentación clínica, el resultado y los fármacos asociados con la reexposición ... -
Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions.
Pinazo-Bandera, Jose M.; Niu, Hao; Alvarez-Alvarez, Ismael; Medina-Cáliz, Inmaculada; Del Campo-Herrera, Enrique; Ortega-Alonso, Aida; Robles‑Diaz, Mercedes; Hernandez, Nelia; Parana, Raymundo; Nunes, Vinicius; Girala, Marcos; Bessone, Fernando; Lucena-González, María Isabel; Andrade-Bellido, Raúl Jesús; García-Cortés, Miren[et al.] (Elsevier, 2024)
Introduction: Data on positive rechallenge in idiosyncratic drug-induced liver injury (DILI) are scarce. We aim to analyse the clinical presentation, outcome and drugs associated with positive rechallenge in two DILI ...